A Phase I/II Randomized Placebo-Controlled, Double-Blind, Single-Center, Tolerability and Preliminary Efficacy Clinical Trial of Recombinant Human Deoxyribonuclease (rhDNase) Eye Drops in Patients With Ocular Graft-Vs.-Host Disease
Phase of Trial: Phase I/II
Latest Information Update: 12 Oct 2016
At a glance
- Drugs Dornase alfa (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 03 Oct 2016 Status changed from not yet recruiting to recruiting.
- 12 Mar 2016 New trial record
- 11 Mar 2016 Planned initiation date changed from 1 Sep 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov record.